Antitumor and antimetastatic effect of small immunostimulatory RNA against B16 melanoma in mice

19Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Small interfering RNAs, depending on their structure, delivery system and sequence, can stimulate innate and adaptive immunity. The aim of this study was to investigate the antitumor and antimetastatic effects of immunostimulatory 19-bp dsRNA with 3’- trinucleotide overhangs (isRNA) on melanoma B16 in C57Bl/6 mice. Recently developed novel cationic liposomes 2X3-DOPE were used for the in vivo delivery of isRNA. Administration of isRNA/2X3DOPE complexes significantly inhibits melanoma tumor growth and metastasis. Histopathological analysis of spleen cross sections showed hyperplasia of the lymphoid white pulp and formation of large germinal centers after isRNA/2X3-DOPE administration, indicating activation of the immune system. The treatment of melanoma-bearing mice with isRNA/2X3-DOPE decreases the destructive changes in the liver parenchyma. Thus, the developed isRNA displays pronounced immunostimulatory, antitumor and antimetastatic properties against melanoma B16 and may be considered a potential agent in the immunotherapy of melanoma.

Cite

CITATION STYLE

APA

Kabilova, T. O., Sen’kova, A. V., Nikolin, V. P., Popova, N. A., Zenkova, M. A., Vlassov, V. V., & Chernolovskaya, E. L. (2016). Antitumor and antimetastatic effect of small immunostimulatory RNA against B16 melanoma in mice. PLoS ONE, 11(3). https://doi.org/10.1371/journal.pone.0150751

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free